Yorktown Management & Research Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-4,000
| Closed | -$217K | – | 304 |
|
|
2016
Q2 | $217K | Hold |
4,000
| – | – | 0.05% | 260 |
|
|
2016
Q1 | $203K | Sell |
4,000
-36,000
| -90% | -$1.83M | 0.04% | 329 |
|
|
2015
Q4 | $2.02M | Sell |
40,000
-36,000
| -47% | -$1.82M | 0.36% | 94 |
|
|
2015
Q3 | $3.65M | Hold |
76,000
| – | – | 0.6% | 44 |
|
|
2015
Q2 | $3.96M | Buy |
76,000
+54,400
| +252% | +$2.83M | 0.69% | 40 |
|
|
2015
Q1 | $1.25M | Buy |
+21,600
| New | +$1.25M | 0.23% | 96 |
|
|
2014
Q3 | – | Sell |
-3,760
| Closed | -$251K | – | 476 |
|
|
2014
Q2 | $251K | Hold |
3,760
| – | – | 0.05% | 317 |
|
|
2014
Q1 | $251K | Hold |
3,760
| – | – | 0.05% | 310 |
|
|
2013
Q4 | $251K | Hold |
3,760
| – | – | 0.05% | 297 |
|
|
2013
Q3 | $236K | Hold |
3,760
| – | – | 0.05% | 266 |
|
|
2013
Q2 | $235K | Buy |
+3,760
| New | +$235K | 0.05% | 227 |
|